 |
市场调查报告书
商品编码
1967564
肠内支架市场：市场规模、占有率、监管、报销、介入治疗及2036年预测（依细分市场划分）Enteral Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
肠内支架市场－市场规模、占有率、监管、报销、介入治疗及2036年预测（依细分市场划分）－旨在可视化呈现一般外科器械治疗领域的定量和定性市场趋势。
肠内支架是一种可穿透的扩张管，插入体内通道以缓解疾病引起的血流阻塞。它们主要用于维持胃肠道管腔的通畅。肠内支架是一种安宁疗护措施，适用于有胃肠道阻塞风险的患者。
肠内支架是一种安宁疗护措施，适用于有胃肠道阻塞风险的患者。 高风险患者通常患有食道癌、胰腺癌、胃癌或大肠癌，肿瘤要么直接侵犯胃肠道，要么造成危险的压迫。肠内支架能够维持胃肠道通畅，并显着改善患者的生活品质。
涵盖的39个国家的市场模型均采用颜色编码，并包含完整的资料来源，其中包括基于流行病学的适应症和干预次数。互动式Excel表格提供价值、销售、产品使用率、平均售价、市场规模和公司占有率分析（如有）。此外，分析师的评论和定性见解为定量数据提供了背景资讯。
市场模型的关键组成部分包括：
目前可用的肠内支架及不断变化的竞争格局
- 对关键产业趋势的深入分析
- 2015年至2036年肠内支架市场依细分市场划分的年度总收入及市场预测
- 依细分市场划分的介入治疗总数、销售量、平均售价和市场规模的详细数据
全球、区域和国家层面的市场洞察
- 除了定性的市场特定资讯外，我们还提供依区域划分的全球趋势细分分析。此外，GlobalData分析师也提供针对特定国家市场的独特见解。
- 肠内支架市场的SWOT分析。
- 肠内支架市场的竞争格局与趋势。
全面、整体的视角，包括对医疗保健系统的概述，有助于加深对市场的理解。此外， "市场准入" 部分透过报销政策和监管环境的讯息，使用户能够更深入地了解市场动态。
- 各国医疗保健系统概述。
- 各国报销政策。
- 各国医疗科技监管环境。
凭藉可靠的研究方法和资料来源，该模型提供了全面而准确的市场概览。主要需求和供应方资讯被整合到一个包含关键产业专家的综合模型中。此外，还利用政府程式资料库、医院采购资料库和专有线上资料库等真实世界资料来源来确定市场趋势。
涵盖的公司包括：波士顿科学公司、威尔逊-库克医疗公司、美瑞医疗系统公司、南京微科医疗股份有限公司、泰雄医疗股份有限公司、迈泰医疗股份有限公司等。
涵盖国家：美国、英国、德国、法国、义大利、西班牙、巴西、中国、印度、俄罗斯、日本、澳洲、加拿大、墨西哥、韩国、丹麦、爱尔兰、荷兰、纽西兰、南非、瑞典、瑞士、奥地利、比利时、芬兰、以色列、挪威、波兰、葡萄牙、台湾、捷克、希腊、匈牙利、土耳其、埃及、沙乌地阿拉伯、阿拉伯联合大公国、阿根廷和智利。
适用范围
此市场模型提供其他地方无法获得的关键专业知识。该模型揭示了特定市场内的定性和定量趋势。以下人员必须阅读此模型：
- 需要深入了解肠内支架市场以指导策略规划和投资决策的首席行销长 (CMO)。
- 需要了解供应链关键组成部分以做出供应商选择和管理决策的采购主管。
- 私募股权投资者需要更深入地了解市场，以便识别和评估潜在的投资目标。
购买理由
此模型可协助您：
- 透过产品线审查识别关键公司，并制定和设计许可引进和许可输出策略。
- 了解影响和驱动肠内支架市场的趋势，并制定业务策略。
- 透过了解关键趋势、创新产品和技术、市场细分以及未来可能影响肠内支架市场的公司，实现收入成长。
- 了解竞争格局，并分析市场领导者的市场占有率，以製定有效的销售和行销策略。
- 识别具有潜在强大产品组合的新兴公司，并制定有效的应对策略以获得竞争优势。
- 追踪2015年至2036年全球及各国肠道支架市场的销售情况。
- 识别最具整合、投资和策略联盟机会的市场类别和细分市场，以优化您的销售和行销策略。
Enteral Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.
An Enteral Stent is a perforated expandable tube which is inserted into a passage of the body in order to alleviate the constriction of flow caused by any disease. Enteral stents are primarily used to maintain patency of the lumen of the gastrointestinal tract. Enteral stents are a palliative measure, used in patients who are at risk of suffering from a blocked gastrointestinal passage.
Enteral stents are a palliative measure, used in patients who are at risk of suffering from a blocked gastrointestinal passage. Those who are at risk are usually suffering from esophogeal, pancreatic, gastric, or colorectal cancer and have tumors that either directly invade the gastrointestinal tract, or cause dangerous compression. Enteral stents can allow the gastrointestinal lumen to stay open, which can drastically improve the quality of life for the patient.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with Intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Enteral Stents and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total Enteral Stents market revenue by segment and market outlooks from 2015-2036.
- Granular data on total Interventions, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for Enteral Stents market.
- Competitive dynamics insights and trends provided for Enteral Stents market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Scientific Corp, Wilson-Cook Medical Inc, Merit Medical Systems Inc, Micro-Tech Nanjing Co Ltd, Taewoong Medical Co Ltd, MITech Co Ltd, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the Enteral Stents marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
- Develop business strategies by understanding the trends shaping and driving Enteral Stents market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Enteral Stents market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Enteral Stents market from 2015-2036.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
